Loading...
XASXMPL
Market cap6.47bUSD
Dec 20, Last price  
3.76AUD
1D
-0.53%
1Q
3.01%
Jan 2017
33.33%
IPO
79.05%
Name

Medibank Private Ltd

Chart & Performance

D1W1MN
XASX:MPL chart
P/E
20.86
P/S
1.29
EPS
0.18
Div Yield, %
4.12%
Shrs. gr., 5y
—
Rev. gr., 5y
3.47%
Revenues
8.02b
+7.53%
6,005,000,0006,485,700,0006,681,600,0006,807,400,0006,948,100,0006,576,900,0006,765,000,0006,832,400,0006,984,400,0007,197,700,0007,460,100,0008,021,600,000
Net income
493m
-3.64%
232,700,000130,800,000285,300,000417,600,000449,500,000445,100,000458,700,000315,000,000441,200,000393,900,000511,100,000492,500,000
CFO
869m
+236.37%
104,501,000312,800,000377,100,000352,300,000393,400,000408,300,000416,100,000600,200,000498,200,000962,700,000258,200,000868,500,000
Dividend
Sep 04, 20240.094 AUD/sh
Earnings
Feb 20, 2025

Profile

Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.
URL
https://www.medibank.com.au
IPO date
Nov 25, 2014
Employees
3,242
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
8,021,600
7.53%
7,460,100
3.65%
7,197,700
3.05%
Cost of revenue
926,800
303,400
249,800
Unusual Expense (Income)
NOPBT
7,094,800
7,156,700
6,947,900
NOPBT Margin
88.45%
95.93%
96.53%
Operating Taxes
215,300
216,000
166,100
Tax Rate
3.03%
3.02%
2.39%
NOPAT
6,879,500
6,940,700
6,781,800
Net income
492,500
-3.64%
511,100
29.75%
393,900
-10.72%
Dividends
(426,900)
(374,500)
(358,000)
Dividend yield
4.16%
3.86%
4.00%
Proceeds from repurchase of equity
(7,500)
(4,900)
38,800
BB yield
0.07%
0.05%
-0.43%
Debt
Debt current
66,600
30,900
30,200
Long-term debt
335,100
48,800
46,700
Deferred revenue
Other long-term liabilities
2,228,600
972,800
1,006,700
Net debt
(3,396,200)
(3,325,300)
(3,478,000)
Cash flow
Cash from operating activities
868,500
258,200
962,700
CAPEX
(7,000)
(41,900)
(35,100)
Cash from investing activities
(110,800)
(15,200)
(637,800)
Cash from financing activities
(487,300)
(419,100)
(399,900)
FCF
4,595,600
7,014,000
6,808,000
Balance
Cash
927,900
420,600
596,700
Long term investments
2,870,000
2,984,400
2,958,200
Excess cash
3,396,820
3,031,995
3,195,015
Stockholders' equity
2,305,100
2,084,400
1,945,600
Invested Capital
2,107,000
754,200
919,900
ROIC
480.88%
829.19%
704.13%
ROCE
160.80%
252.12%
242.47%
EV
Common stock shares outstanding
2,754,003
2,754,003
2,754,003
Price
3.73
5.97%
3.52
8.31%
3.25
2.85%
Market cap
10,272,432
5.97%
9,694,091
8.31%
8,950,511
2.85%
EV
6,875,632
6,368,791
5,472,511
EBITDA
7,184,200
7,236,200
7,025,100
EV/EBITDA
0.96
0.88
0.78
Interest
5,400
1,800
2,400
Interest/NOPBT
0.08%
0.03%
0.03%